Stockscreener 앱 받기
27.91
1.35%
-0.175
Rigel Pharmaceuticals 주식(RIGL)의 최신 뉴스
Rigel Pharmaceuticals Q1 Earnings Call Highlights - Yahoo Finance
Rigel Pharmaceuticals reports Q1 EPS 44c, consensus 87c - TipRanks
Rigel Pharmaceuticals : Quarterly Report for Quarter Ending MARCH 31, 2026 (Form 10-Q) - marketscreener.com
Rigel Pharmaceuticals (RIGL) Lags Q1 Earnings and Revenue Estimates - Yahoo Finance
Earnings call transcript: Rigel Pharmaceuticals Q1 2026 sees revenue growth, stock dips - Investing.com
Rigel Pharmaceuticals Q1 2026 Earnings Call: Complete Transcript - Benzinga
Rigel Pharmaceuticals (NASDAQ:RIGL) Q1 2026 Results Miss Revenue and EPS Estimates, Stock Declines After-Hours - ChartMill
Rigel: Q1 Earnings Snapshot - marketscreener.com
Rigel (NASDAQ: RIGL) grows Q1 2026 sales, ends Lilly RIPK1 deal - Stock Titan
Rigel (NASDAQ: RIGL) grows Q1 2026 drug sales, reaffirms 2026 outlook - Stock Titan
Rigel Reports First Quarter 2026 Financial Results - PR Newswire
MSN Money - MSN
Hussman Strategic Advisors Inc. Buys New Shares in Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Buys Shares of 55,200 Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
RIGL Stock Price, Quote & Chart | RIGEL PHARMACEUTICALS INC (NASDAQ:RIGL) - ChartMill
Q1 2026 results and business update set for May 5, Rigel Pharmaceuticals confirms - Traders Union
Earnings Preview: RIGL to Report Financial Results Post-market on May 05 - 富途牛牛
Rigel Pharmaceuticals (RIGL) to report Q1 results: Wall Street expects earnings growth - MSN
Rigel Announces Conference Call and Webcast to Report First Quar - GuruFocus
Is the options market predicting a spike in Rigel Pharmaceuticals stock? - MSN
Rigel Pharmaceuticals (RIGL) to Release Earnings on Tuesday - MarketBeat
Rigel Pharmaceuticals (RIGL) to Report Q1 Results: Wall Street Expects Earnings Growth - Yahoo Finance
Rigel Announces Conference Call and Webcast to Report First Quarter 2026 Financial Results - Moomoo
RIGEL PHARMACEUTICALS INC (RIGL) Fundamental Analysis & Valuation - ChartMill
Piper Sandler Maintains Rigel Pharmaceuticals(RIGL.US) With Hold Rating, Cuts Target Price to $40 - 富途牛牛
Behavioral Patterns of RIGL and Institutional Flows - Stock Traders Daily
Is the Options Market Predicting a Spike in Rigel Pharmaceuticals Stock? - Yahoo Finance
Eli Lilly terminates agreement with Rigel Pharmaceuticals - medwatch.com
Eli Lilly terminates license agreement with Rigel over ocadusertib - MSN
Ruffer LLP Invests $1.60 Million in Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
RIGL (Rigel Pharmaceuticals Inc.) climbs two percent after Q4 2025 results, even as EPS falls short of analyst forecasts.Verified Stock Signals - Xã Châu Thành
Biopharma bites: Sarclisa's delayed review, Lilly exits Rigel pact, Amneal's biosimilar buy and more from Sanofi, Ipsen - FirstWord Pharma
Lilly reneges on remainder of Rigel deal in another blow for RIPK1 inhibitors - Fierce Biotech
Rigel Pharmaceuticals (NASDAQ:RIGL) Shares Down 5.1%Time to Sell? - MarketBeat
Lilly exits Rigel alliance, adding to RIPK1 scrap heap - BioSpace
H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57 - Moomoo
Eli Lilly Ends Collaboration with Rigel Pharmaceuticals (LLY) - GuruFocus
Rigel Pharmaceuticals Inc on April 16, received written notice from Eli Lilly - marketscreener.com
Rigel Pharmaceuticals Inc On April 16, Received Written Notice From Eli Lilly - TradingView
Rigel Pharmaceuticals to regain rights to ocadusertib after Eli Lilly ends agreement - Investing.com Nigeria
Rigel Regains Rights as Eli Lilly Ends Collaboration - TipRanks
Rigel Pharmaceuticals to Regain Rights as Lilly Terminates RIPK1 License and Collaboration - TradingView
Eli Lilly ends Rigel (RIGL) RIPK1 licensing deal, no future milestones - Stock Titan
Rigel Pharmaceuticals (RIGL) Stock: Reversal Signals (-0.90%) 2026-04-16High Attention Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: A Biotech Player with 59.70% Upside Potential - DirectorsTalk Interviews
(RIGL) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Why Rigel Pharmaceuticals Lost Big in December - AOL.com
Ritholtz Wealth Management Boosts Rigel Pharmaceuticals Holdings - National Today
Ritholtz Wealth Management Acquires 72,999 Shares of Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat
Why VAALCO Energy, Rigel Pharmaceuticals, and Companhia Siderurgica Nacional Are Today's 3 Best Stoc - Yahoo
0.78%
3.01%
자본화:
|
볼륨(24시간):